Celltrion Acquires Eli Lilly’s U.S. Biopharma Plant Amid Tariff Threats
Seoul: Celltrion Inc., South Korea’s leading biopharmaceutical company, announced that its U.S. subsidiary has signed a deal to acquire a U.S. biopharmaceutical production facility. The